口服布洛芬丁香酚酯微乳在大鼠体内药动学研究

赵秀丽;陈大为;胡海洋;乔明曦

中国药学杂志 ›› 2008, Vol. 43 ›› Issue (07) : 532-534.

中国药学杂志 ›› 2008, Vol. 43 ›› Issue (07) : 532-534.
论著

口服布洛芬丁香酚酯微乳在大鼠体内药动学研究

  • 赵秀丽;陈大为;胡海洋;乔明曦
作者信息 +

Study on Pharmacokinetics of Oral Ibuprofen Eugenol Ester Microemulsion in Rats

  • ZHAO Xiu-li, CHEN Da-wei, HU Hai-yang, QIAO Ming-xi
Author information +
文章历史 +

摘要

目的研究布洛芬丁香酚酯微乳剂的抗溃疡作用及其在大鼠体内的药动学。方法采用显微镜法考察布洛芬丁香酚酯微乳的抗溃疡作用。大鼠口服给药后,分别于0.5,1,2,3,4,5,6,8,10和12h取血。采用高效液相色谱法测定血浆中布洛芬的浓度。结果布洛芬丁香酚酯微乳可明显降低小鼠溃疡的发生率。布洛芬丁香酚酯微乳及布洛芬溶液组口服后的AUC0-12分别为(270.31±58.32)和(155.07±39.77)mg·h·L-1,ρmax分别为(64.6±10.34)和(39.94±9.72)mg·L-1,tmax均为1h。MRT0-12分别为(3.69±0.06)和(3.62±0.54)h。结论布洛芬丁香酚酯微乳能降低由布洛芬引起的胃溃疡的发生率,口服给药后可以提高布洛芬的生物利用度。

Abstract

OBJECTIVE To investigate the pharmacokinetics of ibuprofen eugenol ester microemulsion(IEE-ME) in rats.METHODS The protective effect of IEE-ME and ibuprofen on ulcer was assessed pathologically in mice.Following the oral administration of IEE-ME or ibuprofen solution into rats,the blood samples were collected at 0.5,1,2,3,4,5,6,8,10 and 12 h and the plasma ibuprofen concentration was then quantified by HPLC.RESULTS The IEE-ME decreased the ulcerogenic percent obviously.The pharmacokintic parameters of the IEE-IEE and the solution were followed as:AUC0-12 were(270.31±58.32) and(55.07±39.77) mg·h·L-1,ρmax(64.6±10.34) and(39.94±9.72) mg·L-1,tmax 1 and 1 h,MRT0-12(3.69±0.06) and(3.62±0.54)h,respectively.CONCLUSION IEE-ME can decrease ulcerogenic probability induced by ibuprofen,and enhance the bioavailability of ibuprofen after oral IEE-ME.

关键词

布洛芬丁香酚 / 微乳 / 前体药物 / 抗溃疡作用 / 药动学

Key words

ibuprofen eugenol ester / microemulsion / prodrug / anti-ulcerogenic effect / pharmacokinetics

引用本文

导出引用
赵秀丽;陈大为;胡海洋;乔明曦. 口服布洛芬丁香酚酯微乳在大鼠体内药动学研究[J]. 中国药学杂志, 2008, 43(07): 532-534
ZHO Xiu-li;CHEN D-wei;HU Hi-yng;QIO Ming-xi. Study on Pharmacokinetics of Oral Ibuprofen Eugenol Ester Microemulsion in Rats [J]. Chinese Pharmaceutical Journal, 2008, 43(07): 532-534

参考文献

[1] LAPORTE J R, CARNE X,VIDAL X, et al. Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs Catalan Countries Study on Upper Gastrointestinal Blleding[J] .Lancet, 1991,337:85-89. [2] WYNNE H A, LONGE A, NICHOLSON E,et al. Are altered pharmacokinetics of non-steroidal anti-inflammatory drugs (NSAIDs) a risk factor for gastrointestinal bleeding[J] .Br J Clin Pharmacol, 1998,45(4):405-408. [3] CIOLI V, PUTZOLU S, ROSSI V, et al.The role of direct tissue contace in the production of gastrointestinal ulcers by anti-inflammatory drugs in rats [J] .Toxicol Appl Phramcol, 1979, 50:283-289. [4] SHANBHAG V R, CRIDER A M, GOKHALE R,et al. Easters and amide prodrugs of ibuprofen and naproxen: synthesis, antiinflammtory activity, and gastrointestinal toxicity[J] .J Pharm Sci, 1992, 81:149-154. [5] WNAG H X, JIANG X T. Research progression of microemulsion[J] .Foreign Med Sci (Sec Pharm)(国外医学·药学分册), 1996, 23 (4):206-211. [6] CAO Z S, LU F Q. Microemulsion and application in pharmaceutical formulation[J] .World Clin Drugs(世界临床药物), 1993, 14(5):289-293. [7] SWARBRICK J.Edited by Jrg Kreuter. Colloidal Drug Delivery Systems (Drug and the Pharmaceutical Sciences)[M] .the 66th textbook, Wilmington Inc, North Carolina, America,1994. [8] ZHAO X L,CHEN D W, SUN L,et al. Identification of major metabolites of eugenol ester in rats by liquid chromatography/ion trap mass spectrometry[J] .Chin Pharm J(中国药学杂志), 2005, 21:1666-1670.

28

Accesses

0

Citation

Detail

段落导航
相关文章

/